# Glamyo Technologies Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glamyo-technologies-private

- Industry: Healthcare
- Headquarters: New Delhi, India
- Website: www.glamyohealth.in
- Total disclosed funding: $5.2M
- Latest round: Series B (Sep 27, 2022)
- Investors on record: 6

## About

Glamyo Technologies Private Limited provides comprehensive healthcare solutions focusing on elective surgical procedures, enhancing patient experiences through innovative technology and a network of skilled professionals.Founded in 2019, Glamyo Technologies Private Limited operates from New Delhi, India, specializing in elective surgeries and related medical services. The company was established to address the growing demand for advanced healthcare solutions and has secured INR 48.96 mn in SERIES B funding from Agility Venture Partners in September 2022, which is the total amount raised to date. Archit Garg, the founder, has a background in healthcare innovations and operations, contributing to the company's strategic vision and implementation.Glamyo Health specializes in providing advanced healthcare solutions with a focus on elective surgical procedures. Their offerings include laparoscopic surgeries, orthopedic procedures, and cosmetic surgeries, all tailored to enhance patient comfort and recovery times. By leveraging a network of experienced healthcare professionals and state-of-the-art facilities, the company aims to deliver quality healthcare services primarily to urban markets in India, serving both domestic and international clients.In 2022, Glamyo Health generated revenue of INR 1,541,761.7 with a direct-to-consumer model that facilitates connections between patients and healthcare providers. Revenue comes from service fees for surgical procedures and comprehensive healthcare packages, which include pre-operative consultations and post-operative follow-ups. This transparent pricing structure fosters customer trust and satisfaction.Glamyo Technologies plans to utilize the recent funding raised in September 2022 to design and launch new healthcare products tailored to patient needs, targeting market expansion within India and potential entry into other Southeast Asian markets by 2024. The company aims to enhance its service offerings and improve patient engagement through innovative solutions in healthcare.

## Funding rounds

- Series B, Sep 27, 2022, $0.6M — Agility Venture Partners
- Series A, Oct 21, 2021, $3.8M — Ananta Capital, Udtara Ventures, Agility Venture Partners, We Founder Circle, Dexter Ventures
- Seed, Jun 17, 2021, $0.6M — LVX
- Seed, Feb 15, 2021, $0.2M — We Founder Circle

## Investors

- We Founder Circle (https://capitalatlas.ai/funds/we-founder-circle) — Seed, Series A
- LVX (https://capitalatlas.ai/funds/lvx) — Seed
- Ananta Capital (https://capitalatlas.ai/funds/ananta-capital) — Series A
- Udtara Ventures (https://capitalatlas.ai/funds/udtara-ventures) — Series A
- Agility Venture Partners (https://capitalatlas.ai/funds/agility-venture-partners) — Series A, Series B
- Dexter Ventures (https://capitalatlas.ai/funds/dexter-ventures) — Series A